Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
about
Neuroprotection mediated by inhibition of calpain during acute viral encephalitisXenobiotic perturbation of ER stress and the unfolded protein responseSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsEndoplasmic reticulum stress stimulates p53 expression through NF-κB activationPhase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionCombining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaProtein Disulfide Isomerase Superfamily in Disease and the Regulation of ApoptosisThe human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies.The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cellsActivation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.Unfolded protein response to autophagy as a promising druggable target for anticancer therapy.Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance.The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis.The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome.The unfolded protein response triggered by environmental factors.Sequence-specific alterations of epitope production by HIV protease inhibitors.Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivoHIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity.Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.Ritonavir-Induced Suicidal Death of Human Erythrocytes.
P2860
Q26700065-B297F571-EF88-4E9B-B48F-70911CD5290CQ26998690-91F347EB-0CAB-45EC-A0BE-52A84BBD8D23Q28078896-BCCE046E-DA01-4E80-BE3A-F65BACC68759Q28481673-6506018D-C4FC-4402-8C7D-70C034BE0532Q33427510-B10C0E86-5994-4E00-97F1-3703A976F649Q33642284-E27FE473-7CE9-45C2-976B-BCBFE6BD0AFCQ34051168-C04EC8B4-9C29-4617-8E6D-C649FB04EE20Q34318367-0BB19AA9-AFA3-4ECA-80BE-B93F96AE7729Q35444159-EF9676D7-E044-4E9F-8439-878526DD38D0Q36115692-973E128E-93E1-44B5-96E0-2B766E1836BAQ36121745-603AFD81-C4C3-48FE-B19C-E601C81F3E06Q36364238-7E5D7E00-2DE2-4F10-A53E-FA49141D2A1FQ36403652-8F758837-4006-4B87-9D67-5ED7D7523C2FQ36736534-CFE61FB7-A457-4FD9-88A5-8965E30363D3Q36917366-EA0658AE-8694-4B77-B8B0-0078EDC418F9Q37288354-CB357D61-1F35-4978-82F7-282E20D8EE3AQ38088360-CE268F88-30E7-484D-BE6C-6DFF23A6B1CFQ38095787-28C4A023-83E1-4CDE-8CA4-7BC39059A845Q38710071-F6B33683-963B-4934-BC29-223B22F13E84Q38947274-22B05991-2800-49CB-99F6-16F4AAB0329AQ39407246-0CF1D2FC-663D-4DD5-935A-D1772FE8B8BAQ40314379-74C0D668-3D4E-4948-A5FE-FE2B0EBCA556Q45324487-0071DC22-2A28-48A8-A0A8-ECA892F2B026Q46537249-9BB62F52-0A8A-49B4-966E-B416C6A3B239
P2860
Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@en
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@nl
type
label
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@en
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@nl
prefLabel
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@en
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@nl
P2093
P1476
Ritonavir induces endoplasmic ...... bortezomib-induced apoptosis.
@en
P2093
Christoph Driessen
Elke Malenke
Ewa Koscielniak
Herman Overkleeft
Holger Müller
Jeannette Gogel
Jörg Thomas Hartmann
Marianne Kraus
Thomas Rückrich
P304
P356
10.1158/1535-7163.MCT-07-2375
P577
2008-07-01T00:00:00Z